This report demonstrated that integration of pharmacy liaisons and pharmacists into the appeals process represents a cost-effective, sustainable solution to the administrative challenges faced by prescribers.
Lumicera Health Services today announced the launch of Clarventa, a new company created to address one of the most persistent drivers of rising prescription drug costs: the complex and opaque pharmaceutical supply chain.
Lumicera Health Services is proud to announce that Eric Huckins has been promoted to Chief Growth Officer, a role in which he will guide the next stage of Lumicera’s expansion, partnerships and specialty pharmacy innovation.
Lumicera Earns URAC Rare Disease Pharmacy Center of Excellence Certification, Reinforcing Commitment to Specialized Patient Care.
Lumicera announces the promotion of Ben Heiser, PharmD, to Senior Vice President and Chief Executive Officer (CEO) during a period of historic growth!
Eric Huckins, our Vice President of Business Development, sat down with the Becker’s Healthcare Podcast Network during their CPO Summit to share his insights on specialty pharmacy for health systems.
At Lumicera, clinical excellence isn’t just a goal, it’s the heart of everything we do. Our dedicated pharmacy team goes above and beyond to provide personalized, patient-focused care each and every day!
This report analyzed the patient acceptance rate and reported outcomes when a pharmacist provided interventions for patients on oral targeted breast cancer therapies in a mail order integrated health system specialty pharmacy.
Lumicera Health Services announced today it will be participating in LEO Pharma’s Limited Distribution Network to dispense Anzupgo® (delgocitinib) Cream, the first and only FDA-approved treatment for moderate-to-severe Chronic Hand Eczema (CHE) in adults.
This report explores the background of 340B covered entities, how they operate and the ways Lumicera’s clinical liaison team optimizes these programs for cost savings.
